AML1-ETO interacts with Sp1 and antagonizes Sp1 transactivity through RUNT domain

FEBS Letters

Volumn 582, Issue 15, 2008, Pages 2167-2172

  Wei, Hui ^a   Liu, Xiangrong ^a   Xiong, Xiujuan ^a   Wang, Yang ^a   Rao, Qing ^a   Wang, Min ^a   Wang, Jianxiang ^a  

^a INSTITUTE OF HEMATOLOGY AND BLOOD DISEASES HOSPITAL   (China)

Author keywords

Acute myeloid leukemia; AML1 ETO; Cell differentiation; Sp1; Transcription regulation

Indexed keywords

AML1 ETO PROTEIN; HYBRID PROTEIN; TRANSCRIPTION FACTOR RUNX1; TRANSCRIPTION FACTOR SP1;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; EMBRYO; GENE ACTIVITY; GENE REPRESSION; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; LEUKEMIA; LEUKEMOGENESIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; TRANSACTIVATION;

CELL LINE; CORE BINDING FACTOR ALPHA 2 SUBUNIT; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKOPOIESIS; ONCOGENE PROTEINS, FUSION; PROTEIN STRUCTURE, TERTIARY; SP1 TRANSCRIPTION FACTOR; TRANS-ACTIVATION (GENETICS);

EID: 46549089110     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2008.05.030     Document Type: Article

References (15)

1. Wang J., Hoshino T., Redner R.L., Kajigaya S., and Liu J.M. ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR/mSin3/HDAC1 complex. Proc. Natl. Acad. Sci. USA 95 (1998) 10860-10865
2. Westendorf J.J., Yamamoto C.M., Lenny N., Downing J.R., Selsted M.E., and Hiebert S.W. The t(8;21) fusion product, AML-1-ETO, associates with C/EBP-alpha, inhibits C/EBP-alpha-dependent transcription, and blocks granulocytic differentiation. Mol. Cell Biol. 18 (1998) 322-333
3. Vangala R.K., Heiss-Neumann M.S., Rangatia J.S., Singh S.M., Schoch C., Tenen D.G., Hiddemann W., and Behre G. The myeloid master regulator transcription factor PU.1 is inactivated by AML1-ETO in t(8;21) myeloid leukemia. Blood 101 (2003) 270-277
4. Koschmieder S., Agrawal S., Radomska H.S., Huettner C.S., Tenen D.G., Ottmann O.G., Berdel W.E., Serve H.L., and Müller-Tidow C. Decitabine and vitamin D3 differentially affect hematopoietic transcription factors to induce monocytic differentiation. Int. J. Oncol. 30 (2007) 349-355
5. el-Deiry W.S., Tokino T., Velculescu V.E., Levy D.B., Parsons R., Trent J.M., Lin D., Mercer W.E., Kinzler K.W., and Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell 75 (1993) 817-825
6. Nakano K., Mizuno T., Sowa Y., Orita T., Yoshino T., Okuyama Y., Fujita T., Ohtani-Fujita N., Matsukawa Y., Tokino T., Yamagishi H., Oka T., Nomura H., and Sakai T. Butyrate activates the WAF1/Cip1 gene promoter through Sp1 sites in a p53-negative human colon cancer cell line. J. Biol. Chem. 272 (1997) 22199-22206
7. Parks C.L., and Shenk T. The serotonin 1a receptor gene contains a TATA-less promoter that responds to MAZ and Sp1. J. Biol. Chem. 271 (1996) 4417-4430
8. Lutterbach B., Westendorf J.J., Linggi B., Isaac S., Seto E., and Hiebert S.W. A mechanism of repression by acute myeloid leukemia-1, the target of multiple chromosomal translocations in acute leukemia. J. Biol. Chem. 275 (2000) 651-656
9. J Brightbill H.D., Plevy S.E., Modlin R.L., and Smale S.T. A prominent role for Sp1 during lipopolysaccharide-mediated induction of the IL-10 promoter in macrophages. J. Immunol. 164 (2000) 1940-1951
10. Wei H., Liu X.R., Liu H., Rao Q., Wang M., and Wang J.X. Effects of AML1-ETO on transcription activity of p21WAF1/CIP1 gene promoter. Zhonghua Xue Ye Xue Za Zhi 28 (2007) 545-548
11. Xiao H., Hasegawa T., and Isobe K. Both Sp1 and Sp3 are responsible for p21waf1 promoter activity induced by histone deacetylase inhibitor in NIH3T3 cells. J. Cell Biochem. 73 (1999) 291-302
12. Dynan W.S., and Tjian R. The promoter-specific transcription factor Sp1 binds to upstream sequences in the SV40 early promoter. Cell 35 (1983) 79-87
13. Burel S.A., Harakawa N., Zhou L., Pabst T., Tenen D.G., and Zhang D.E. Dichotomy of AML1-ETO functions: growth arrest versus block of differentiation. Mol Cell Biol. 21 (2001) 5577-5590
14. Peterson L.F., Yan M., and Zhang D.E. The p21Waf1 pathway is involved in blocking leukemogenesis by the t(8; 21) fusion protein AML1 -ETO. Blood 109 (2007) 4392-4398
15. Hauses M., Tönjes R.R., and Grez M. The transcription factor Sp1 regulates the myeloid-specific expression of the human hematopoietic cell kinase (HCK) gene through binding to two adjacent GC boxes within the HCK promoter-proximal region. J. Biol. Chem. 273 (1998) 31844-31852